Development of a phenyl-bridged bis-β-carboline-crosslinked hyaluronic acid polymer: synergistic eradication of drug-resistant Gram-positive bacteria
RSC Pharmaceutics · 2026
DOI: 10.1039/d6pm00138f ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Pharmaceutics, 2026. Verfasst von Suravi Chauhan und 7 weiteren Autor:innen. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: Department of Biotechnology, Ministry of Science and Technology.
Abstract (Originalsprache)
A hyaluronidase-responsive hyaluronic acid hydrogel crosslinked with phenyl-bridged bis-β-carboline was developed to combat bacteria and biofilms, improve ciprofloxacin efficacy, limit resistance development, and promote wound healing.
Förderung
- Department of Biotechnology, Ministry of Science and Technology
Zitieren
APA
Chauhan, S., Paul, S., Kar, M. K., Karn, R., Raj, N., Datta, D., Bhattacharjee, S., & Manna, D. (2026). Development of a phenyl-bridged bis-β-carboline-crosslinked hyaluronic acid polymer: synergistic eradication of drug-resistant Gram-positive bacteria. RSC Pharmaceutics. https://doi.org/10.1039/d6pm00138f
Vancouver
Chauhan S, Paul S, Kar MK, Karn R, Raj N, Datta D, et al. Development of a phenyl-bridged bis-β-carboline-crosslinked hyaluronic acid polymer: synergistic eradication of drug-resistant Gram-positive bacteria. RSC Pharmaceutics. 2026. doi:10.1039/d6pm00138f
BibTeX
@article{Chauhan2026,
author = {Chauhan, Suravi and Paul, Suman and Kar, Mrinal Kanti and Karn, Rama and Raj, Naveen and Datta, Debajyoti and Bhattacharjee, Surajit and Manna, Debasis},
title = {Development of a phenyl-bridged bis-β-carboline-crosslinked hyaluronic acid polymer: synergistic eradication of drug-resistant Gram-positive bacteria},
journal = {RSC Pharmaceutics},
year = {2026},
doi = {10.1039/d6pm00138f}
}
EUVIMED